Effect of proteolytic inhibitors on growth and surface architecture of normal and transformed cells.
D000372:Agglutination Tests; D000818:Animals; D001120:Arginine / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects*; D002462:Cell Membrane / Q000187:drug effects*; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured / Q000187:drug effects*; D002713:Chlorine / Q000494:pharmacology; D003208:Concanavalin A / Q000494:pharmacology; D003260:Contact Inhibition / Q000187:drug effects*; D005347:Fibroblasts; D008239:Lysine / Q000494:pharmacology; D051379:Mice; D011480:Protease Inhibitors; D013539:Simian virus 40; D014105:Tosyl Compounds / Q000494:pharmacology
D011480:Protease Inhibitors; D014105:Tosyl Compounds; D003208:Concanavalin A; D002713:Chlorine; D001120:Arginine; D008239:Lysine